[Fabry's disease. Carbamazepine therapy in acrodyniform syndrome].
A 19 year old male affected with Fabry's disease suffered from severe nervous manifestations. Despite very peculiar pains of the extremities, the diagnosis has been missed for a long time and was painted out at this age because of sharp reconstitution of the family history. Fabry's disease was confirmed by discovering typical corneal lesion, a low leucocyte (W.B.C.) alpha-galactosidase activity and foam cells in renal glomerular epithelium. The importance of an early diagnosis is obvious in this case: 10 Instead of degrading narcotic therapy, Carbamazepin brought forward normal social and school living. 20 Familial investigations show up that all the siblings were affected (three boys including the propositus)--several symptoms were found in the heterozygous conductor mother. Despite the rarety of Fabry's disease, the authors emphasize the easiness of diagnosis on simple clinical and biochemical grounds. The authors insist on the symptomatic and therapeutic action of Carbamazepin or Diphenytoin in order to prevent painfull symptoms which often appear during initial course of the disease.
D000328:Adult; D002220:Carbamazepine / Q000627:therapeutic use*; D003316:Corneal Diseases / Q000209:etiology; D000795:Fabry Disease / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007678:Kidney Glomerulus / Q000473:pathology; D007958:Leukocyte Count; D008297:Male; D009461:Neurologic Manifestations
D002220:Carbamazepine
La maladie de Fabry. Traitement du syndrome acrodyniforme par la carbamazepine.